4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-20-063226
Director sold 37,782 shares at an average $18.02 ($680,657)
- Director acquired 37,782 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ZASLOFF MICHAEL A Director | 2020-05-14 | Option exercise | +14,832 | $15.11 | $224,112 | 50,168 | D |
| ZASLOFF MICHAEL A Director | 2020-05-14 | Sale | −14,832 | $18.00 | $266,976 | 35,336 | D |
| ZASLOFF MICHAEL A Director | 2020-05-15 | Option exercise | +22,950 | $15.11 | $346,775 | 58,286 | D |
| ZASLOFF MICHAEL A Director | 2020-05-15 | Sale | −22,950 | $18.03 | $413,681 | 35,336 | D |
| Derivatives | |||||||
| ZASLOFF MICHAEL A Director | 2020-05-14 | Option exercise · Stock Option (right to buy) | −14,832 | 22,950 | D | ||
| ZASLOFF MICHAEL A Director | 2020-05-15 | Option exercise · Stock Option (right to buy) | −22,950 | 0 | D | ||
| Open-market sales · 37,782 sh · avg $18.02 · $680,657 | |||||||
Loading xslF345X03/a4.xml…